Pfizer buys Seagen for $43B, boosts access to cancer drugs
Pfizer buys Seagen for $43B, boosts access to cancer drugs
1 week ago
1
Pfizer is spending astir $43 cardinal to scope deeper into caller crab treatments that people tumor cells portion sparing surrounding steadfast tissue.